Eagle Bay Advisors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-216
| Closed | -$460 | – | 150 |
|
|
2024
Q4 | $460 | Hold |
216
| – | – | ﹤0.01% | 965 |
|
|
2024
Q3 | $605 | Hold |
216
| – | – | ﹤0.01% | 1310 |
|
|
2024
Q2 | $503 | Hold |
216
| – | – | ﹤0.01% | 959 |
|
|
2024
Q1 | $966 | Hold |
216
| – | – | ﹤0.01% | 929 |
|
|
2023
Q4 | $693 | Hold |
216
| – | – | ﹤0.01% | 793 |
|
|
2023
Q3 | $685 | Hold |
216
| – | – | ﹤0.01% | 811 |
|
|
2023
Q2 | $1.07K | Buy |
216
+108
| +100% | +$537 | ﹤0.01% | 799 |
|
|
2023
Q1 | $534 | Hold |
108
| – | – | ﹤0.01% | 865 |
|
|
2022
Q4 | $679 | Hold |
108
| – | – | ﹤0.01% | 844 |
|
|
2022
Q3 | $1K | Hold |
108
| – | – | ﹤0.01% | 790 |
|
|
2022
Q2 | $1.23K | Buy |
+108
| New | +$1.23K | ﹤0.01% | 838 |
|
|
2022
Q1 | – | Sell |
-108
| Closed | -$2K | – | 313 |
|
|
2021
Q4 | $2K | Hold |
108
| – | – | ﹤0.01% | 858 |
|
|
2021
Q3 | $3K | Hold |
108
| – | – | ﹤0.01% | 857 |
|
|
2021
Q2 | $3K | Buy |
+108
| New | +$3K | ﹤0.01% | 787 |
|